Latest period
$36.87M
YoY change
-17.6%
5Y CAGR
-19.3%
Peak year (2023)
$156.35M
Cumulative CapEx
$267.83M
CapEx history chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: $8.89M
CapEx growth chart for Teladoc Health (TDOC) from 2013 to 2025
Latest: -17.6%
CapEx history table for Teladoc Health (TDOC) from 2013 to 2025
| 2025 | $8.89M | -17.6% | −$1.90M | ||
| 2024 | $10.79M | -93.1% | −$145.56M | ||
| 2023 | $156.35M | +848.7% | +$139.87M | ||
| 2022 | $16.48M | +93.1% | +$7.95M | ||
| 2021 | $8.53M | -67.2% | −$17.51M | ||
| 2020 | $26.04M | +138.9% | +$15.14M | ||
| 2019 | $10.90M | +29.7% | +$2.49M | ||
| 2018 | $8.41M | +52.4% | +$2.89M | ||
| 2017 | $5.51M | +61.6% | +$2.10M | ||
| 2016 | $3.41M | -56.4% | −$4.41M | ||
| 2015 | $7.82M | +350.8% | +$6.08M | ||
| 2014 | $1.73M | +34.0% | +$440.00K | ||
| 2013 | $1.29M | — | — |
- 2025$8.89M-17.6%
- 2024$10.79M-93.1%
- 2023$156.35M+848.7%
- 2022$16.48M+93.1%
- 2021$8.53M-67.2%
- 2020$26.04M+138.9%
- 2019$10.90M+29.7%
- 2018$8.41M+52.4%
- 2017$5.51M+61.6%
- 2016$3.41M-56.4%
- 2015$7.82M+350.8%
- 2014$1.73M+34.0%
- 2013$1.29M—
CapEx values are taken from Teladoc Health's reported cash flow statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About CapEx at Teladoc Health (TDOC)
According to Teladoc Health's latest reported financial statements, the company's current CapEx (TTM) is $36.87M. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
2025's annual CapEx for Teladoc Health (TDOC) came in at $8.89M – declined 17.6% year-over-year.
Teladoc Health CapEx compound annual growth for the 2020–2025 (5 years) window is -19.3%, with a net decline across the window.
Teladoc Health CapEx plunged from $156.35M in 2023 to $8.89M in 2025, a 94.3% drawdown.
The highest annual CapEx of $156.35M was reported in 2023. The lowest in the available history was $1.29M in 2013.
Teladoc Health Capital Expenditures by Year
Teladoc Health Capital Expenditures 2025: $8.89M
Teladoc Health CapEx in 2025 was $8.89M, declined 17.6% below 2024.
Teladoc Health Capital Expenditures 2024: $10.79M
2024's CapEx for Teladoc Health came in at $10.79M, plunged 93.1% below 2023.
Teladoc Health Capital Expenditures 2023: $156.35M
Teladoc Health posted CapEx of $156.35M in 2023, surged 848.7% from 2022. This figure represents the highest annual value in the available history.
Teladoc Health Capital Expenditures 2022: $16.48M
In 2022, Teladoc Health reported CapEx of $16.48M, surged 93.1% from 2021.
Teladoc Health Capital Expenditures 2021: $8.53M
Teladoc Health CapEx in 2021 was $8.53M.
See more financial history for Teladoc Health (TDOC).
Sector peers by CapEx
Healthcare peers of Teladoc Health (TDOC), ranked by their latest CapEx
| $14.05B | |
| $7.84B | |
| $4.83B | |
| $4.11B | |
| $3.62B | |
| $2.81B | |
| $1.86B | |
| $1.21B |
- $14.05B
- $7.84B
- $4.83B
- $4.11B
- $3.62B
- $2.81B
- $1.86B
- $1.21B
Frequently asked questions
Teladoc Health (TDOC) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation